Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study

Autor: Caryn S, Ross-Innes, Irene, Debiram-Beecham, Maria, O'Donovan, Elaine, Walker, Sibu, Varghese, Pierre, Lao-Sirieix, Laurence, Lovat, Michael, Griffin, Krish, Ragunath, Rehan, Haidry, Sarmed S, Sami, Philip, Kaye, Marco, Novelli, Babett, Disep, Richard, Ostler, Benoit, Aigret, Bernard V, North, Pradeep, Bhandari, Adam, Haycock, Danielle, Morris, Stephen, Attwood, Anjan, Dhar, Colin, Rees, Matthew D D, Rutter, Peter D, Sasieni, Rebecca C, Fitzgerald, Sharon, Cave

Publikováno v: Ross-Innes, C S, Debiram-Beecham, I, O'Donovan, M, Walker, E, Varghese, S, Lao-Sirieix, P, Lovat, L, Griffin, M, Ragunath, K, Haidry, R, Sami, S S, Kaye, P, Novelli, M, Disep, B, Ostler, R, Aigret, B, North, B V, Bhandari, P, Haycock, A, Morris, D, Attwood, S, Dhar, A, Rees, C, Rutter, M D D, Sasieni, P D & Fitzgerald, R C 2015, ' Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus : A Multi-Center Case–Control Study ', PLoS Medicine, vol. 12, no. 1, e1001780 . https://doi.org/10.1371/journal.pmed.1001780
PLoS Medicine
PLoS Medicine, Vol 12, Iss 1, p e1001780 (2015)

Background Barrett's esophagus (BE) is a commonly undiagnosed condition that predisposes to esophageal adenocarcinoma. Routine endoscopic screening for BE is not recommended because of the burden this would impose on the health care system. The objec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55ffac5eb22389dbfab29d33677ecb97
https://pubmed.ncbi.nlm.nih.gov/25645931